Cynthia J. TenEyck

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.

Loi K. Phuong, Cory Allen, Kah Whye Peng et al. · PubMed · 2003 · 250 citations

Synthetic Virology, Immunology, Cell Death +19

1357. Intraperitoneal Therapy of Ovarian Cancer Using an Engineered Measles Virus

Kah-Whye Peng, Cynthia J. TenEyck, Evanthia Galanis et al. · Molecular Therapy · 2002 · 224 citations · Full text

Engineered Measles Virus, Median Survival, Medicine +15

Up-regulation of Heat Shock Protein 27 Induces Resistance to 17-Allylamino-Demethoxygeldanamycin through a Glutathione-Mediated Mechanism

Andrea K. McCollum, Cynthia J. TenEyck, Brian M. Sauer et al. · Cancer Research · 2006 · 156 citations · Full text

HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924

Paul Haluska, Joan M. Carboni, Cynthia J. TenEyck et al. · Molecular Cancer Therapeutics · 2008 · 101 citations · Full text

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors

Ramesh K. Ramanathan, Merrill J. Egorin, Charles Erlichman et al. · Journal of Clinical Oncology · 2010 · 87 citations · Full text